<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 17:36:41" record="45657" source="Espacenet">
	<entities>
		<entity ref="Patent45657" type="Patent">
			<semanticIdentifier>brcris::83d12502b047d43555f03a1ba41e0c92</semanticIdentifier>
			<semanticIdentifier>docdb::BR102019019689A2</semanticIdentifier>
			<semanticIdentifier>epodoc::BR102019019689</semanticIdentifier>
			<semanticIdentifier>docdb::BR102019019689A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR20191019689</semanticIdentifier>
			<semanticIdentifier>original::102019019689</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=102019019689"/>
			<field name="identifier.lattes" value="6352367545519988"/>
			<field name="identifier.espacenet" value="102019019689"/>
			<field name="kindCode" value="A2"/>
			<field name="title.espacenet" value="derivados 2-amino-tiofênicos como agentes antifúngicos"/>
			<field name="title.lattes" value="DERIVADOS TIOFÊNICOS COMO AGENTES ANTIFÚNGICOS"/>
			<field name="depositDate" value="2019-09-20"/>
			<field name="publicationDate" value="2021-04-06"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="FRANCISCO JAIME BEZERRA MENDONCA JUNIOR"/>
			<field name="inventor" value="ISADORA SILVA LUNA"/>
			<field name="inventor" value="REGINALDO GONCALVES DE LIMA NETO"/>
			<field name="inventor" value="REJANE PEREIRA NEVES"/>
			<field name="inventor" value="WENDELL WONS NEVES"/>
			<field name="applicant" value="UNIVERSIDADE FEDERAL DE PERNAMBUCO"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="A61K9/16AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="16AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61P31/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61P31/10AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="10AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="4"/>
				<field name="text" value="C07D333/10AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="D"/>
				<field name="group" value="333"/>
				<field name="subgroup" value="10AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="5"/>
				<field name="text" value="C07D495/02AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="D"/>
				<field name="group" value="495"/>
				<field name="subgroup" value="02AI"/>
			</field>
			<field name="abstract.espacenet" value="derivados 2-amino-tiofênicos como agentes antifúngicos. a presente patente de invenção aborda novos compostos sintéticos derivados de 2-amino-tiofênicos, que apresentam ação antifúngica. os precursores 2-amino-tiofênicos apresentados nessa patente foram sintetizados através da quarta versão da reação de gewald. a avaliação in vitro da sensibilidade de espécies dos gêneros candida e cryptococcus, além dos fungos filamentos dos gêneros trichophyton, microsporum, epidermophyton contra 19 derivados 2-amino-tiofênicos foi realizada pelo método de microdiluição em caldo. os compostos mais bioativos in vitro seguiram avaliação da toxicidade pela atividade hemolítica. os compostos mais ativos para as leveduras (cim 8 ? 16 µg.ml) foram o cno2, cn06, cn07, cn08, cn10, cn11, cn21 e cn23, sendo o cn07 o que apresentou excelente resultado frente a c.neoformans, com um cim de 8 µg.ml e para dermatófitos (cim 32 - 1.024 µg.ml) cn05, cn06, cn07, cn17, cn19 com cim de até 32 µg/ml para as moléculas cn05, cn19 e cn06. no que se refere a atividade hemolítica, as moléculas cn13 e cn17 apresentaram as menores taxas de hemólise, sendo 2,5 %. diante do exposto, os derivados de tiofeno 2-amino-substituídos demonstram-se moléculas promissoras no desenvolvimento de compostos antifúngicos. estudo in vivo são essenciais para futuras aplicações médicas."/>
			<field name="originatesFrom" value="75620964"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102019019689"/>
				<field name="kind" value="A2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR102019019689"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102019019689"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR20191019689"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value=""/>
				<field name="number" value="102019019689"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person31226" type="Person">
			<semanticIdentifier>lattes::6352367545519988</semanticIdentifier>
			<field name="identifier.lattes" value="6352367545519988"/>
			<field name="name" value="Wendell Wons Neves"/>
		</entity>
		<entity ref="OrgUnit24492" type="OrgUnit">
			<semanticIdentifier>brcris::0ec00e3600e4262d0376f8058f832118</semanticIdentifier>
			<field name="name" value="UNIVERSIDADE FEDERAL DE PERNAMBUCO"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent45657" toEntityRef="Person31226" type="Inventor"/>
		<relation fromEntityRef="Patent45657" toEntityRef="OrgUnit24492" type="Applicant"/>
	</relations>
</entity-relation-data>
